JP Morgan Chase
GUTS icon

JP Morgan Chase’s Fractyl Health GUTS Stock Holding History

JP Morgan Chase’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$399 Hold
934
– – ﹤0.01% 7197
2025
Q4 		$2.06K Sell
934
-49,810
-98% -$80.2K ﹤0.01% 6940
2025
Q3 		$80.7K Buy
+50,744
New +$65.8K ﹤0.01% 6026
2025
Q2 		– Sell
-17,100
Closed -$20.3K – 7730
2025
Q1 		$20.3K Buy
17,100
+1,131
+7% +$1.81K ﹤0.01% 6148
2024
Q4 		$32.9K Buy
15,969
+1,162
+8% +$2.71K ﹤0.01% 6136
2024
Q3 		$37.5K Buy
14,807
+11,406
+335% +$37.2K ﹤0.01% 6078
2024
Q2 		$14.5K Sell
3,401
-35,357
-91% -$227K ﹤0.01% 6199
2024
Q1 		$287K Buy
+38,758
New +$326K ﹤0.01% 5130

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase's GUTS Position: Q1 2026 in Review

JP Morgan Chase held its Fractyl Health (GUTS) position steady in Q1 2026 at 934 shares worth $399. The position accounts for ﹤0.01% of the portfolio, ranked #7197.

JP Morgan Chase first reported a position in GUTS in Q1 2024 and has held it in 8 quarters since. The position peaked at $287K in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • JP Morgan Chase held 934 shares of Fractyl Health worth $399 as of Q1 2026.
  • JP Morgan Chase left its Fractyl Health share count unchanged in Q1 2026.
  • Fractyl Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7197 holding.
  • JP Morgan Chase first reported a position in Fractyl Health in Q1 2024 and has held it in 8 quarters since.
  • JP Morgan Chase's Fractyl Health position peaked at $287K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.